Endovascular revascularization vs. open surgical revascularization for patients with lower extremity artery disease:
Hongxin Shu1, Xiaowei Xiong2, Xiaomei Chen3
1The Second Clinical Medical School, Nanchang University, Nanchang, China.
Insights
Endovascular revascularization (EVR) offers lower short-term risks for lower extremity artery disease (LEAD), while open surgical revascularization (OSR) provides better long-term outcomes. Patient life expectancy is crucial when selecting LEAD treatment.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Health Outcomes Research
Background:
- Lower extremity artery disease (LEAD) treatment primarily involves revascularization, with endovascular revascularization (EVR) and open surgical revascularization (OSR) being common modalities.
- The optimal revascularization strategy for LEAD remains a subject of ongoing debate and controversy within the medical community.
Purpose of the Study:
- To provide a comprehensive review of recent evidence comparing endovascular revascularization (EVR) and open surgical revascularization (OSR) for treating lower extremity artery disease (LEAD).
- To analyze and synthesize data from randomized controlled trials (RCTs) and cohort studies to inform clinical decision-making for LEAD management.
Main Methods:
- A systematic literature search was conducted across Medline, Embase, and the Cochrane Library databases.
- Included studies were randomized controlled trials (RCTs) and cohort studies comparing short-term and long-term outcomes of EVR versus OSR in LEAD patients.
- Outcomes assessed included mortality, amputation rates, complications, cardiovascular events, hospital stay, survival, re-intervention rates, and vessel patency.
Main Results:
- Analysis of 11 RCTs and 105 cohort studies involving 750,134 patients.
- Pooled cohort data indicated EVR significantly reduced 30-day mortality, wound complications, MACEs, and LOS, but increased risks for OS, FFR, PP, and SP.
- Pooled RCT data showed EVR was associated with lower 30-day mortality, fewer wound complications, and shorter LOS, but a higher risk of PP and SP. No significant difference in 30-day major amputation or AFS was observed.
Conclusions:
- Both cohort studies and RCTs suggest EVR offers lower short-term risks for LEAD, whereas OSR demonstrates a substantially lower long-term risk.
- The choice of revascularization modality for LEAD should carefully consider the patient's life expectancy.
- Further high-quality studies are necessary to validate these findings, as current evidence largely relies on retrospective cohort data.
Background:
Currently, the main treatment for lower extremity artery disease (LEAD) is revascularization, including endovascular revascularization (EVR) and open surgical revascularization (OSR), but the specific revascularization strategy for LEAD is controversial. This review provided the comprehensive and recent evidence for the treatment of LEAD.
Methods:
Medline, Embase, and the Cochrane Library databases were searched for relevant articles. Randomized controlled trials (RCTs) and cohort studies comparing the short-term or long-term outcomes between EVR and OSR of LEAD were identified. Short-term outcomes were 30-day mortality, major amputation, wound complication, major adverse cardiovascular events (MACEs), and length of hospital stay (LOS), while long-term outcomes included overall survival (OS), amputation-free survival (AFS), freedom from re-intervention (FFR), primary patency (PP), and secondary patency (SP).
Results:
11 RCTs and 105 cohorts involving 750,134 patients were included in this analysis. For the pooled results of cohort studies, EVR markedly decreased the risk of 30-day mortality, wound complication, MACEs, LOS, but increased the risk of OS, FFR, PP, and SP. For the pooled outcomes of RCTs, EVR was associated with obviously lower 30-day mortality, less wound complication and shorter LOS, but higher risk of PP, and SP. However, both RCTs and cohorts did not show obvious difference in 30-day major amputation and AFS.
Conclusions:
Both the pooled results of cohorts and RCTs indicated that EVR was associated with a lower short-term risk for LEAD, while OSR was accompanied by a substantially lower long-term risk. Therefore, the life expectancy of LEAD should be strictly considered when choosing the revascularization modality. As the current findings mainly based on data of retrospective cohort studies, additional high-quality studies are essential to substantiate these results.
Systematic Review Registration:
https://www.crd.york.ac.uk/PROSPERO/#recordDetails, identifier CRD42022317239.
More Related Videos
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Aneurysm III: Interprofessional Care


